Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07577063 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cohort Study of Metabolic Disease and Hypertension

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
5,087 trials monitored
See 222 trials at risk
3,874 trials monitored
See 152 trials at risk
2,231 trials monitored
See 111 trials at risk
and 1 more disease
The goal of this observational study is to learn how type 2 diabetes and high blood pressure develop over time in adults in Mexico. The study will include men and women between 18 and 65 years of age who do not have a previous diagnosis of these conditions. The main questions this study aims to answer are: What factors increase the risk of developing type 2 diabetes? What factors increase the risk of developing high blood pressure? Participants will not receive any experimental treatment. Researchers will observe their health as part of their regular medical care. Participants will: Attend an initial visit that includes physical measurements, blood tests, and questionnaires about their health, lifestyle, and environment Perform a simple walking test to measure physical fitness Return once a year for follow-up visits over a period of five years During the study, researchers will monitor participants to identify new cases of type 2 diabetes and high blood pressure. The results of this study may help improve prevention strategies and support public health programs aimed at reducing chronic diseases in Mexico.
Trial Details
NCT Number NCT07577063
Lead Sponsor Coordinación de Investigación en Salud, Mexico
Collaborators: Secretaria de Salud, Mexico, Instituto Mexicano del Seguro Social
Conditions
(from sponsor)
Type 2 Diabetes Mellitus (T2DM), Hypertension (HTN)
Related terms Diabetes Mellitus, Type 2, Hypertension, Obesity, Prediabetic State, Prehypertension
Enrollment 2,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov